GO:0006887 exocytosis: Vesicle Trafficking Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006887 exocytosis is the biological process by which a cell releases intracellular molecules contained within a membrane-bounded vesicle into the extracellular space.
• Exocytosis can proceed by full fusion, where the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism involving a transient fusion pore that often leads to only partial secretion.
• The process begins with vesicle tethering and docking and ends when molecules are secreted from the cell.
• Exocytosis is essential in neuronal communication, hormone release, immune cytotoxicity, lysosomal membrane repair, and viral egress [2,4,6,8].
• Core molecular players include SNARE proteins, Rabs, Munc18, synaptotagmin, and calcium sensors that regulate fusion [1,7].
• Dysregulated exocytosis contributes to cancer progression, neurodegeneration, immune disorders, and pathogen dissemination [2,4,6,8].
Description
Exocytosis (GO:0006887) is a fundamental cellular secretion process in which intracellular molecules stored within membrane-bounded vesicles are released from the cell. It is a highly conserved mechanism that supports neuronal communication, hormone secretion, immune surveillance, and membrane remodeling [1,5,7]. The process encompasses vesicle tethering, docking, priming, calcium-triggered fusion, and content release, and can occur through full fusion or kiss-and-run modes. Because exocytosis is central to both normal physiology and disease, it is a major focus of cell biology, neuroscience, immunology, and cancer research [3,5,6]. Defects in exocytosis underlie disorders ranging from neurodegeneration to immune dysfunction, while pathogens such as SARS-CoV-2 and herpesviruses exploit exocytic pathways for egress [2,8]. Understanding the molecular machinery and regulatory logic of exocytosis is therefore essential for developing targeted therapies and for interpreting functional genomics screens [4,7].
exocytosis At A Glance
| GO ID | GO:0006887 |
|---|---|
| GO term | exocytosis |
| Ontology | biological_process |
| Synonym | nonselective vesicle exocytosis; vesicle exocytosis |
| Major function | Release of intracellular molecules contained within membrane-bounded vesicles into the extracellular space |
| Mechanisms | Full fusion or kiss-and-run transient fusion pore |
| Start | Vesicle tethering and docking |
| End | Secretion of molecules from the cell |
| Example cell type | Chromaffin cells (granule exocytosis) |
What Is GO:0006887?
According to the Gene Ontology, exocytosis (GO:0006887) is a process of secretion by a cell that results in the release of intracellular molecules, such as hormones or matrix proteins, contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for example of chromaffin cells) and the plasma membrane; the latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell. Synonyms include nonselective vesicle exocytosis and vesicle exocytosis.
Why Is exocytosis Important in Cell Biology?
Exocytosis is essential for intercellular communication, hormone and neurotransmitter release, immune cytotoxicity, lysosomal repair, and pathogen egress, making it a central process in physiology and disease [1,2,4,6,8]. Its dysfunction is linked to neurological, immune, and metabolic disorders, and its machinery is co-opted by viruses and tumor cells [2,4,8]. Studying exocytosis provides mechanistic insight into secretion, membrane trafficking, and therapeutic targets [3,5,7].
• Enables neurotransmitter release and synaptic transmission in the nervous system [1,6].
• Controls hormone secretion from endocrine cells and chromaffin granules [1,7].
• Mediates lytic granule release for immune cytotoxicity at immune synapses.
• Supports lysosomal exocytosis for membrane repair and cellular protection.
• Is exploited by SARS-CoV-2 ORF3a for lysosomal exocytosis-mediated viral egress.
• Is involved in herpesvirus STING exocytosis pathway during infection.
• Contributes to protumoral functions when lysosomal exocytosis is deregulated.
• Requires SNARE proteins, Rabs, Munc18, and synaptotagmin for fusion [1,7].
• Can be unproductive, leading to incomplete or failed secretion.
• Is a target for functional genomics and CRISPR screening to identify regulators [5,7].
What Happens During exocytosis?
Vesicle Tethering and Docking
In simple terms: The vesicle is captured and held near the plasma membrane before fusion.
Exocytosis begins with steps that prepare vesicles for fusion with the membrane, including tethering and docking. Tethering factors and Rab GTPases mediate the initial capture of vesicles at the target membrane, while docking establishes a stable contact that precedes priming [1,7]. These early steps are essential for spatial and temporal control of secretion and are conserved across neuronal and non-neuronal cells [5,7].
Priming and Calcium Sensing
In simple terms: The vesicle is made ready to fuse, and a calcium sensor waits for the signal.
Priming renders vesicles fusion-competent through the action of SNARE proteins and accessory factors such as Munc18 and synaptotagmin [1,7]. Calcium influx triggers synaptotagmin-dependent fusion, enabling rapid release in neurons and endocrine cells [1,7]. In non-neuronal cells, similar priming and calcium-sensing mechanisms regulate secretion.
Full Fusion and Kiss-and-Run
In simple terms: The vesicle either merges completely with the membrane or opens a brief pore.
Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule and the plasma membrane. The kiss-and-run mode most of the time leads to only partial secretion of the granule content. Both modes are observed in chromaffin cells and other secretory systems [1,3].
Content Release and Membrane Retrieval
In simple terms: Molecules exit the cell, and the membrane is recycled.
Exocytosis ends when molecules are secreted from the cell. Following release, membrane retrieval pathways recycle vesicular components to sustain repeated rounds of secretion [1,7]. Unproductive exocytosis can occur when fusion fails to release content efficiently, highlighting the need for precise regulation.
Specialized Exocytic Routes
In simple terms: Different cell types use exocytosis for specialized jobs.
Lysosomal exocytosis mediates cell protection and can acquire protumoral functions. Lytic granule exocytosis at immune synapses shares lessons from neuronal synapses. Viruses such as SARS-CoV-2 and herpesviruses exploit exocytic pathways for egress [2,8].
Key Genes Involved in GO:0006887 exocytosis
The following genes and proteins are core components of the exocytosis machinery and are frequently studied in functional screens.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STX1A | SNARE protein mediating vesicle fusion | Neuronal and endocrine secretion models |
| SNAP25 | SNARE protein forming fusion complex | Neurotransmitter release studies |
| VAMP2 | Vesicle-associated SNARE | Synaptic vesicle exocytosis |
| RAB3A | Regulates vesicle docking and priming | Secretory granule trafficking |
| RAB27A | Controls lytic granule exocytosis | Immune cytotoxicity and pigmentation |
| UNC13A | Priming factor for vesicle fusion | Synaptic transmission and neurodegeneration |
| STXBP1 | Munc18-1, regulates SNARE complex assembly | Neurodevelopmental disorders |
| SYT1 | Calcium sensor for fast fusion | Synaptic and endocrine release |
| SYT7 | Calcium-dependent exocytosis regulator | Lysosomal exocytosis and repair |
| MUNC13 | Priming machinery component | Secretion studies |
| RAB11A | Regulates vesicle recycling | Membrane retrieval |
| RAB11B | Vesicle trafficking regulator | Exocytosis and recycling |
| SNAP23 | Non-neuronal SNARE | Mast cell and epithelial secretion |
| STX4 | Plasma membrane SNARE | Insulin secretion |
| VAMP7 | Lysosomal SNARE | Lysosomal exocytosis |
| RAB5A | Early endosome regulator | Endocytic-exocytic crosstalk |
| RAB7A | Late endosome/lysosome trafficking | Lysosomal exocytosis |
| STX3 | Apical SNARE | Epithelial secretion |
How Is exocytosis Regulated?
Exocytosis is regulated by calcium signaling, SNARE complex assembly, Rab GTPase cycles, and accessory proteins such as Munc18 and synaptotagmin [1,7]. In non-neuronal cells, similar regulatory logic controls secretion. Pathogens can modulate exocytic pathways, as seen with SARS-CoV-2 ORF3a promoting lysosomal exocytosis and herpesviruses tracing STING exocytosis. Unproductive exocytosis can occur when regulatory steps fail.
exocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAB27A | Immune cytotoxicity defects | Knockout in cytotoxic T cells |
| STXBP1 | Neurodevelopmental disorders | Point mutation knock-in in neurons |
| SYT1 | Neurological dysfunction | Knockout in neuronal cultures |
| ORF3a (viral) | SARS-CoV-2 egress | Overexpression in epithelial cells |
| STING | Herpesvirus infection | Knockout in macrophages |
Exocytosis in Cancer
Lysosomal exocytosis can shift from cell protection to protumoral functions, contributing to cancer progression. Deregulated secretion supports tumor microenvironment remodeling and metastasis.
Exocytosis in Neurodegeneration
Defects in synaptic vesicle exocytosis are linked to neurodegeneration and neurodevelopmental disorders [1,7]. Unproductive exocytosis may impair neuronal communication.
Exocytosis in Infectious Disease
SARS-CoV-2 ORF3a promotes lysosomal exocytosis-mediated viral egress. Herpesviruses exploit STING exocytosis during infection.
Exocytosis in Immune Disorders
Lytic granule exocytosis at immune synapses is essential for cytotoxicity, and its failure leads to immune dysfunction.
From exocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate exocytosis? | CRISPR knockout in secretory cells |
| Does a disease variant alter fusion? | Point mutation knock-in |
| Where does the protein localize? | Tagged knock-in (e.g., GFP) |
| Does overexpression enhance secretion? | Overexpression cell line |
| Which genes are essential for exocytosis? | CRISPR library screening |
| What pathways are altered? | Bioinformatics and RNA-seq |
How to Study the exocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Vesicle fusion dynamics | Secretory cell studies |
| Patch-clamp capacitance | Fusion pore and full fusion | Chromaffin cells |
| Proteomics | Protein composition of vesicles | SNARE complex analysis |
| CRISPR screening | Gene essentiality for exocytosis | Functional genomics |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Super-resolution microscopy | Nanoscale fusion sites | Immune synapse studies |
| Flow cytometry | Surface marker externalization | Lysosomal exocytosis assays |
Live-Cell Imaging
Live-cell imaging with fluorescently tagged vesicles and membrane markers visualizes tethering, docking, and fusion events in real time [1,5].
Electrophysiology
Patch-clamp capacitance measurements detect single-vesicle fusion and kiss-and-run events in chromaffin and neuronal cells [1,3].
Proteomics
Proteomic analysis of vesicle fractions identifies SNARE complexes and accessory proteins involved in exocytosis.
CRISPR Screening
Genome-wide CRISPR screens identify regulators of exocytosis and secretion pathways [5,7].
How CRISPR Can Be Used to Study GO:0006887 exocytosis
Knockout
CRISPR knockout of exocytosis genes such as RAB27A or STXBP1 abolishes secretion and reveals essential functions [1,6].
Point Mutation
Point mutation knock-in models disease variants in SNARE or calcium-sensor genes to test fusion defects.
Knock-in
Tagged knock-in of exocytic proteins enables live tracking of vesicle trafficking.
Overexpression
Overexpression of viral ORF3a or STING enhances exocytic egress pathways [2,8].
How EDITGENE Supports exocytosis Research
Researchers studying exocytosis-related genes often need to determine whether a candidate gene is causally involved in vesicle trafficking, secretion, or disease-associated dysfunction. EDITGENE provides CRISPR-based cell models to test these hypotheses with precision.
Contact EDITGENE today to design your custom CRISPR model for exocytosis research.
Frequently Asked Questions About exocytosis
What is exocytosis GO:0006887?
Exocytosis is a process of secretion by a cell that results in the release of intracellular molecules contained within a membrane-bounded vesicle.
What genes are involved in exocytosis?
Key genes include STX1A, SNAP25, VAMP2, RAB3A, RAB27A, UNC13A, STXBP1, and SYT1 [1,7].
What are the two main types of exocytosis?
Full fusion and kiss-and-run, the latter involving a transient fusion pore.
How is exocytosis regulated?
By calcium signaling, SNARE complex assembly, Rab GTPases, and accessory proteins [1,7].
What diseases involve exocytosis?
Cancer, neurodegeneration, infectious disease, and immune disorders [2,4,6,8].
How do viruses use exocytosis?
SARS-CoV-2 ORF3a promotes lysosomal exocytosis for egress, and herpesviruses exploit STING exocytosis [2,8].
What is lysosomal exocytosis?
A form of exocytosis where lysosomes fuse with the plasma membrane, involved in repair and protumoral functions.
What methods study exocytosis?
Live-cell imaging, patch-clamp capacitance, proteomics, and CRISPR screening [1,5,7].
What is unproductive exocytosis?
A failed or incomplete secretion event that does not efficiently release vesicle content.
How can CRISPR help study exocytosis?
Knockout, point mutation, knock-in, and overexpression models reveal gene function in secretion [1,7].
Conclusion
Exocytosis (GO:0006887) is a central biological process governing secretion, communication, and membrane dynamics. Its molecular machinery and regulatory logic are conserved across cell types and are implicated in cancer, neurodegeneration, infection, and immune disorders [1,4,6,8]. CRISPR-based models provide powerful tools to dissect exocytosis gene function and identify therapeutic targets [5,7].
References
- 1. Morgan A. 1995. Exocytosis.. Essays Biochem 30:77-95 PMID: 8822150
- 2. Chen D et al.. 2021. ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress.. Dev Cell 56(23):3250-3263.e5 PMID: 34706264
- 3. Kreft M et al.. 2016. Unproductive exocytosis.. J Neurochem 137(6):880-9 PMID: 26841731
- 4. Trojani MC et al.. 2024. Lysosomal exocytosis: From cell protection to protumoral functions.. Cancer Lett 597:217024 PMID: 38871244
- 5. Thorn P et al.. 2016. Exocytosis in non-neuronal cells.. J Neurochem 137(6):849-59 PMID: 26938142
- 6. Chang HF et al.. 2023. Lytic granule exocytosis at immune synapses: lessons from neuronal synapses.. Front Immunol 14:1177670 PMID: 37275872
- 7. Burgoyne RD et al.. 2003. Secretory granule exocytosis.. Physiol Rev 83(2):581-632 PMID: 12663867
- 8. Dogrammatzis C et al.. 2024. Tracing the STING exocytosis pathway during herpes viruses infection.. mBio 15(4):e0037324 PMID: 38470056
